FDA Clears Breztri for Asthma Use - Top-Institutions - MDSpire

FDA Clears Breztri for Asthma Use

Single-inhaler triple therapy improved lung function vs dual therapy in phase 3 trials and showed rapid onset without new safety signals.

  • By

  • Kathryn Wighton

  • April 28, 2026

  • 2 min

Share

Top Institutions in Pulmonary

Brief introduction explaining scope and methodology.

  • #1

    National Jewish Health
    National Jewish Health

    Denver, CO

    Key Differentiators

    • Pulmonology
    • Allergy and Immunology
    • Asthma Research

  • #2

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Pulmonology
    • Allergy and Immunology
    • Clinical Research

  • #3

    University of Michigan Medical School
    University of Michigan Medical School

    Ann Arbor, MI

    Key Differentiators

    • Pulmonary and Critical Care Medicine
    • Asthma Clinical Trials

  • #4

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Pulmonology
    • Allergy and Immunology

  • #5

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Pulmonology
    • Immunology
    • Clinical Research

Original Source(s)

FDA Clears Breztri for Asthma Use

  • by Kathryn Wighton

  • April 28, 2026

Related Content

miRNA profiling shows shared signatures in pediatric asthma, obesity and their comorbidity

CT Use May Add to Future Cancer Burden

Researchers projected approximately 103,000 future cancers associated with computed tomography examinations performed in the US in 2023.

Antibiotics May Not Help Mild COVID

A retrospective cohort study of more than 520,000 hospitalized patients found no clinically meaningful improvement in deterioration or mortality with early treatment targeting community-acquired pneumonia.